Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMMULOGIC -- Ignore unavailable to you. Want to Upgrade?

To: Bosco who wrote (251)	4/16/1998 9:03:00 PM
From: Harold Engstrom	Read Replies (1) \| Respond to of 305

I owned Immulogic until selling it for tax reasons at the end of last year. I thought the company had great promise with its several vaccine candidates. But the company doesn't know how to run clinicals. Ordinarily, I would say "we'll see", but this company doesn't know how to do anything practical. Imagine selling your pilot facilities when you have products in the pipeline - this is a sure sign that the company can't do anything with its science and is just going to burn through its capital until they close the doors. I talked with an engineer working at Immulogic last fall and he said "get out" because he didn't think any of the allervax vaccines were based on any solid hopes. Not short the stock, just wanted to give some good advice. This was the last stock I will buy on someone else's recommendation.